The use of bioprosthetic valves fabricated from fixed heterograft tissue (porcine aortic valves
or bovine pericardium) in heart valve replacement surgery is limited because of calcification …

Calcification frequently causes failure of bioprosthetic heart valves (BHV) fabricated from
glutaraldehyde‐pretreated porcine aortic valve or bovine pericardium. Systemic …

Studies performed by other investigators have shown that a number of preimplantation
processes inhibit the calcification of pieces of porcine aortic valves and of bovine parietal …

Despite the significant advances in cardiac surgery, heart valve replacement still faces a
dilemma. While mechanical valves offer lifelong durability they also commit patients to …

Calcification-induced stenosis or tearing is the principal cause of failure of clinical heart
valve bioprostheses fabricated from glutaraldehyde-pretreated porcine aortic valves and …

Heart valve replacements fabricated from glutaraldehyde (Glut)-crosslinked heterograft
materials, porcine aortic valves or bovine pericardium, have been widely used in cardiac …

Calcification plays a major role in the failure of bioprosthetic and other tissue heart valve
substitutes. Tissue valve calcification is initiated primarily within residual cells that have …

Calcification is the Principal cause of the clinical faliure of bioprosthetic heart valves (BHV)
fabricated from glutaraldehy de-treated porcine valves or bovine pericardium. This study …

Clinical and experimental studies indicate that calcification of bioprosthetic valves depends
on host, implant, and biomechanical factors. The earliest mineral deposits in both clinical …

Calcification is the most frequent cause of the failure of bioprosthetic heart valves fabricated
from glutaraldehyde pretreated porcine aortic valves or bovine pericardium. Formulation and …